Blueprint Medicines (BPMC) PT Lowered to $103 at JMP Securities
Tweet
Share
E-mailGet Alerts BPMC Hot Sheet
Price: $129.46 --0%
Rating Summary:
11 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 3 | New: 0
Rating Summary:
11 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 3 | New: 0
Join SI Premium – FREE
JMP Securities lowered its price target on Blueprint Medicines (NASDAQ: BPMC) to $103.00 (from $109.00) while maintaining a Market Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Upgrades Shell Plc. (SHEL) to Overweight
- Ayvens SA (AYV:FP) PT Lowered to EUR12.90 at UBS
- HSBC Downgrades Evergreen Marine Corp Taiwan Ltd (2603:TT) to Reduce
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
